These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12504783)
1. A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain. Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G Eur J Pharmacol; 2003 Jan; 458(3):275-82. PubMed ID: 12504783 [TBL] [Abstract][Full Text] [Related]
2. Design and assessment of a potent sodium channel blocking derivative of mexiletine for minimizing experimental neuropathic pain in several rat models. Weston RM; Subasinghe KR; Staikopoulos V; Jarrott B Neurochem Res; 2009 Oct; 34(10):1816-23. PubMed ID: 19504185 [TBL] [Abstract][Full Text] [Related]
3. Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats. Akada Y; Ogawa S; Amano K; Fukudome Y; Yamasaki F; Itoh M; Yamamoto I Eur J Pharmacol; 2006 May; 536(3):248-55. PubMed ID: 16603152 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the anti-nociceptive effects of voltage-activated Na+ channel blockers in the formalin test. Blackburn-Munro G; Ibsen N; Erichsen HK Eur J Pharmacol; 2002 Jun; 445(3):231-8. PubMed ID: 12079688 [TBL] [Abstract][Full Text] [Related]
5. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Lindia JA; Köhler MG; Martin WJ; Abbadie C Pain; 2005 Sep; 117(1-2):145-53. PubMed ID: 16061326 [TBL] [Abstract][Full Text] [Related]
6. Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models. Ghelardini C; Desaphy JF; Muraglia M; Corbo F; Matucci R; Dipalma A; Bertucci C; Pistolozzi M; Nesi M; Norcini M; Franchini C; Camerino DC Neuroscience; 2010 Aug; 169(2):863-73. PubMed ID: 20580661 [TBL] [Abstract][Full Text] [Related]
7. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Garry EM; Delaney A; Anderson HA; Sirinathsinghji EC; Clapp RH; Martin WJ; Kinchington PR; Krah DL; Abbadie C; Fleetwood-Walker SM Pain; 2005 Nov; 118(1-2):97-111. PubMed ID: 16213091 [TBL] [Abstract][Full Text] [Related]
8. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409 [TBL] [Abstract][Full Text] [Related]
9. Pre-emptive intrathecal quinidine alleviates spinal nerve ligation-induced peripheral neuropathic pain. Cheng KI; Wang HC; Lai CS; Tsai HP; Kwan AL; Ho ST; Wang JJ; Chang LL J Pharm Pharmacol; 2011 Aug; 63(8):1063-9. PubMed ID: 21718290 [TBL] [Abstract][Full Text] [Related]
10. The Local and Systemic Actions of Duloxetine in Allodynia and Hyperalgesia Using a Rat Skin Incision Pain Model. Wang CF; Russell G; Strichartz GR; Wang GK Anesth Analg; 2015 Aug; 121(2):532-44. PubMed ID: 26049779 [TBL] [Abstract][Full Text] [Related]
11. The cutaneous analgesic effect of class I antiarrhythmic drugs. Tzeng JI; Cheng KI; Huang KL; Chen YW; Chu KS; Chu CC; Wang JJ Anesth Analg; 2007 Apr; 104(4):955-8. PubMed ID: 17377113 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic investigation of the mechanism underlying cold allodynia using a new cold plate procedure in rats with chronic constriction injuries. Tanimoto-Mori S; Nakazato-Imasato E; Toide K; Kita Y Behav Pharmacol; 2008 Feb; 19(1):85-90. PubMed ID: 18195599 [TBL] [Abstract][Full Text] [Related]
13. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain. Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states. Ilyin VI; Pomonis JD; Whiteside GT; Harrison JE; Pearson MS; Mark L; Turchin PI; Gottshall S; Carter RB; Nguyen P; Hogenkamp DJ; Olanrewaju S; Benjamin E; Woodward RM J Pharmacol Exp Ther; 2006 Sep; 318(3):1083-93. PubMed ID: 16728593 [TBL] [Abstract][Full Text] [Related]
15. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457 [TBL] [Abstract][Full Text] [Related]
16. Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain. Rode F; Jensen DG; Blackburn-Munro G; Bjerrum OJ Eur J Pharmacol; 2005 Jun; 516(2):131-8. PubMed ID: 15936014 [TBL] [Abstract][Full Text] [Related]